1)Jennings MT, et al:Intracranial germ-cell tumors:natural history and pathogenesis. J Neurosurg 63:155-167, 1985
2)Matsutani M, et al:Primary intracranial germ cell tumors:a clinical analysis of 153 histologically verified cases. J Neurosurg 86:446-455, 1997
3)Takami H, et al:Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium. Neuro Oncol 21:1565-1577, 2019
4)Takami H, et al:The third eye sees double:cohort study of clinical presentation, histology, surgical approaches, and ophthalmic outcomes in pineal region germ cell tumors. World Neurosurg 150:e482-e490, 2021
5)Takami H, et al:Epidemiology, natural history, and optimal management of neurohypophyseal germ cell tumors. J Neurosurg 134:437-445, 2021[Online Publication Date:07 Feb 2020]
6)Gittleman H, et al:Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015. J Neurooncol 143:251-260, 2019
7)McCarthy BJ, et al:Primary CNS germ cell tumors in Japan and the United States:an analysis of 4 tumor registries. Neuro Oncol 14:1194-1200, 2012
8)Takami H, et al:Comparison on epidemiology, tumor location, histology, and prognosis of intracranial germ cell tumors between Mayo Clinic and Japanese consortium cohorts. J Neurosurg 134:446-456, 2021[Online Publication Date:31 Jan 2020]
9)Calaminus G, et al:SIOP CNS GCT 96:final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol 15:788-796, 2013
10)Matsutani M;Japanese Pediatric Brain Tumor Study Group:Combined chemotherapy and radiation therapy for CNS germ cell tumors--the Japanese experience. J Neurooncol 54:311-316, 2001
11)Fangusaro J, et al:Phase Ⅱ trial of response-based radiation therapy for patients with localized CNS nongerminomatous germ cell tumors:a Children's Oncology Group study. J Clin Oncol 37:3283-3290, 2019
12)Calaminus G, et al:Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol 19:1661-1672, 2017
13)Acharya S, et al:Long-term outcomes and late effects for childhood and young adulthood intracranial germinomas. Neuro Oncol 17:741-746, 2015
14)Cheng S, et al:Outcomes of children with central nervous system germinoma treated with multi-agent chemotherapy followed by reduced radiation. J Neurooncol 127:173-180, 2016
15)Takami H, et al:Novel diagnostic methods and posttreatment clinical phenotypes among intracranial germ cell tumors. Neurosurgery 87:563-572, 2020
16)Murray MJ, et al:Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy. Int J Cancer 141:621-635, 2017
17)Ichimura K, et al;Intracranial Germ Cell Tumor Genome Analysis Consortium:Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy. Acta Neuropathol 131:889-901, 2016
18)Fukushima S, et al;Intracranial Germ Cell Tumor Genome Analysis Consortium(iGCT Consortium):Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas. Acta Neuropathol 127:911-925, 2014
19)Demetri GD, et al:Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472-480, 2002
20)Pectasides D, et al:Complete response after imatinib mesylate administration in a patient with chemoresistant stage Ⅳ seminoma. Anticancer Res 28:2317-2320, 2008
21)Pedersini R, et al:Complete response after treatment with imatinib in pretreated disseminated testicular seminoma with overexpression of c-KIT. Lancet Oncol 8:1039-1040, 2007
22)Wang L, et al:Novel somatic and germline mutations in intracranial germ cell tumours. Nature 511:241-245, 2014
23)Fukushima S, et al;Intracranial Germ Cell Tumor Genome Analysis Consortium(The iGCTConsortium):Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas. Acta Neuropathol 133:445-462, 2017
24)Schulte SL, et al:CNS germinomas are characterized by global demethylation, chromosomal instability and mutational activation of the Kit-, Ras/Raf/Erk- and Akt-pathways. Oncotarget 7:55026-55042, 2016
25)Queipo G, et al:Intracranial germ cell tumors:association with Klinefelter syndrome and sex chromosome aneuploidies. Cytogenet Genome Res 121:211-214, 2008
26)Bonouvrie K, et al:Klinefelter syndrome and germ cell tumors:review of the literature. Int J Pediatr Endocrinol 2020:18, 2020 doi:10.1186/s13633-020-00088-0
27)Miyake Y, et al:Craniospinal germinomas in patient with down syndrome successfully treated with standard-dose chemotherapy and craniospinal irradiation:case report and literature review. World Neurosurg 108:995.e9-995.e15, 2017
28)Murray MJ, et al:Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors. Neurooncol Adv 2:vdaa048, 2020
29)Dieckmann KP, et al:Serum levels of microRNA miR-371a-3p:a sensitive and specific new biomarker for germ cell tumours. Eur Urol 71:213-220, 2017
30)Hsieh T-H, et al:Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors. Neuro Oncol 20:519-530, 2018
31)Hoei-Hansen CE, et al:New evidence for the origin of intracranial germ cell tumours from primordial germ cells:expression of pluripotency and cell differentiation markers. J Pathol 209:25-33, 2006
32)Wang HW, et al:Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations. BMC Genomics 11:132, 2010
33)Takami H, et al:Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors. J Neurooncol 124:23-32, 2015
34)Aihara Y, et al:Placental alkaline phosphatase levels in cerebrospinal fluid can have a decisive role in the differential diagnosis of intracranial germ cell tumors. J Neurosurg 131:687-694, 2018
35)Zapka P, et al:Type, frequency, and spatial distribution of immune cell infiltrates in CNS germinomas:evidence for inflammatory and immunosuppressive mechanisms. J Neuropathol Exp Neurol 77:119-127, 2018
36)Takami H, et al;Intracranial Germ Cell Tumor Genome Analysis Consortium(the iGCT Consortium):Intratumoural immune cell landscape in germinoma reveals multipotent lineages and exhibits prognostic significance. Neuropathol Appl Neurobiol 46:111-124, 2020
37)Takami H, et al:Low tumor cell content predicts favorable prognosis in germinoma patients. Neurooncol Adv 3:vdab110, 2021
38)Goldman S, et al:Phase Ⅱ trial assessing the ability of neoadjuvant chemotherapy with or without second-look surgery to eliminate measurable disease for nongerminomatous germ cell tumors:a Children's Oncology Group study. J Clin Oncol 33:2464-2471, 2015
39)Bartels U, et al:GCT-41. Response-based radiation therapy in patients with newly diagnosed central nervous system localized germinoma:a Children's Oncology Group(COG)prospective phase 2 clinical trial. Neuro Oncol 22:iii336, 2020
40)Kanamori M, et al:So-called bifocal tumors with diabetes insipidus and negative tumor markers:are they all germinoma? Neuro Oncol 23:295-303, 2021
41)Kanamori M, et al:Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-a controversy. Neurooncol Adv 3:vdab086, 2021
42)Takami H, et al:Histopathology and prognosis of germ cell tumors metastatic to brain:cohort study. J Neurooncol 154:121-130, 2021
43)Wildeman ME, et al:Central nervous system germinomas express programmed death ligand 1. J Neuropathol Exp Neurol 77:312-316, 2018